相关实验视频
Updated: Jun 23, 2025

13:21
Graphene Coatings for Biomedical Implants
Published on: March 1, 2013
21.3K
作为表面生物活性涂层的阿伦德罗酸盐:对CaP-阿伦德罗酸盐相互作用的研究
Ines Despotović1, Željka Petrović2, Jozefina Katić3
1Division of Physical Chemistry, Ruđer Bošković Institute, Bijenička Cesta 54, 10002 Zagreb, Croatia.
Materials (Basel, Switzerland)
|June 19, 2024
概括
植入物上的阿伦德罗酸涂层促进了自发酸沉积,增强了骨质整合. 这种生物材料表面修饰改善了牙植入物的生物活性和骨结合.
科学领域:
- 生物材料科学 生物材料科学
- 表面化学 表面化学
- 牙科植入物学 牙科植入物学
背景情况:
- 牙植入成功取决于影响组织相互作用和骨融合的表面特性.
- 促进酸 (CaP) 层形成的生物活性涂层可以增强骨结合和内生长.
研究的目的:
- 为了研究与alendronate修改的表面上的自发CaP沉积.
- 为了阐明控制CaP核化和生长在阿伦德罗酸涂层上的机制.
主要方法:
- 综合实验和理论方法.
- 量子化学计算 (密度函数理论 - DFT).
- 使用SEM,EDX,XRD和ATR-FTIR光谱学进行表面表征.
主要成果:
- 在氧化物表面上发生自发的CaP核化,用负的吉布斯自由能量来表示.
- 由Ca2+ - 酸盐相互作用和结合驱动的CaP沉积.
- 实验证实了CaP在阿伦德罗酸涂层的表面上的形成.
结论:
- 阿伦德罗酸涂层有助于在上自发的生物活性CaP层的形成.
- 这种表面修饰增强了牙科植入物的生物活性.
- 结果为开发用于牙科植入物的先进生物材料提供了指导.
相关概念视频
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K

